How to commission evaluations of national policy pilots

To help policy makers who plan national pilot programmes and their evaluations, PIRU has developed a guidance document “Advice and how to commission national policy pilot evaluations”. The document is available here >>

Payment-for-performance: incentivising quality in public services

PIRU’s event on payment-for-performance (P4P) held in February 2013 reviewed the evidence for P4P and its evaluation. The event brought together research and policy experts for an evening of presentations and a panel discussion to explore the gains that may be made by applying P4P techniques, as well as an appraisal of the limitations.
Full details and a range of post-event outputs including downloadable slides, videos of the presentations and panel discussion, interviews, summaries and blogs are available here >>

The Responsibility Deal - Supersized Health Promotion

Mark Petticrew, Professor of Public Health Evaluation at LSHTM

We can surely only get healthier, it would seem, when the public sector, academics and voluntary organisations team up with the food, drinks and leisure sectors to promote healthy living. That’s the claim behind the Government’s Public Health Responsibility Deal.


Forging social care policy amid the white heat of a White Paper
Martin Knapp, Professor of Social Policy at LSE

With the Government’s White Paper on Social Care expected soon, all eyes are turned to an area of just a few hundred square metres inWestminster.


Desperately seeking the Steve Jobs of healthcare modelling

James Barlow, Professor of Technology and Innovation Management at Imperial College London

We know that health services need a shake-up. How else can we meet ever increasing demand while holding down costs and improving quality and productivity?


Too much spin can seriously damage the health of spin-offs

Nick Mays, PIRU Director

The recent Department of Health report, 'Innovation, Health and Wealth'* tells an intriguing story about the potential economic benefits of the NHS.


How PIRU aims to make a difference

Nick Mays, PIRU Director

Governments these days are less interested in simply supplying services and much more concerned to guarantee results, regardless of how services are provided. That’s true particularly for healthcare.


Alternatives to the chemical cosh

Bob Erens, PIRU Deputy Director

There is wide concern about anti-psychotic drugs — the so-called ‘chemical cosh’ — being prescribed far too readily for patients with dementia, particularly in care homes.